Naloxone Hydrochloride (Akorn, Inc.)
Welcome to the PulseAid listing for the Naloxone Hydrochloride drug offered from Akorn, Inc.. This Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Naloxone Hydrochloride |
SUBSTANCE NAME: | NALOXONE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-02-28 |
END MARKETING DATE: | 0000-00-00 |
Naloxone Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Naloxone Hydrochloride from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.4(mg/mL) |
START MARKETING DATE: | 2017-02-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-041_230e2d93-1fe2-4cdf-90ed-ed1b965dfd46 |
PRODUCT NDC: | 17478-041 |
APPLICATION NUMBER: | ANDA208871 |
Other NALOXONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: